Company: RACE
Filing Date: 2025-02-26
Form Type: 424B7
Source: 0001104659-25-017340
Chunk: 33

Company: Ferrari N.V.
Filing Date: 2025-02-26
Form: 424B7
Chunk 33
---
 common shares. If common shares are offered pursuant to this prospectus, we will provide a prospectus supplement and attach it to this prospectus. The prospectus supplement will contain more specific information about the offering, including the number of common shares to be sold by the selling shareholder. The prospectus supplement may also add, update or change information contained in this prospectus. You should read this prospectus and the accompanying prospectus supplement, as well as the documents incorporated by reference herein or therein, carefully before you make your investment decision.

This prospectus may not be used to sell securities unless it is accompanied by a prospectus supplement.

Our common shares may be sold at fixed prices, prevailing market prices at the times of sale, prices related to the prevailing market prices, varying prices determined at the times of sale or negotiated prices. Our common shares offered by this prospectus and the accompanying prospectus supplement may be offered by the selling shareholder directly to investors or to or through underwriters, dealers or other agents. More information about how our common shares may be offered and sold is set forth in the section entitled “Plan of Distribution” beginning on page 16. The prospectus supplement for an offering will describe in detail the plan of distribution for the offering and will set forth the names of any underwriters, dealers or agents involved in the offering and any applicable fees, commissions or discount arrangements.

In the United States, our common shares are listed and traded on the New York Stock Exchange (the “NYSE”) under the symbol “RACE”. Our common shares are also listed and traded on Euronext Milan under the symbol “RACE”.

Investing in our securities involves certain risks. See “Risk Factors” beginning on page 3.

Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.**

#### Prospectus dated February 26, 2025
TABLE OF CONTENTS

TABLE OF CONTENTS

| ​ | ABOUT THIS PROSPECTUS                                    | ​ | ​ | ​ | ​ |  1 | ​ | ​ |
| ​ | RISK FACTORS                                             | ​ | ​ | ​ | ​ |  3 | ​ | ​ |
| ​ | FORWARD-LOOKING STATEMENTS                               | ​ | ​ | ​ | ​ |  4 | ​ | ​ |
| ​ | INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE          | ​ | ​